as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
4.33%
Downside
0.79%
Upside
52 Week's Low
52 Week's High
79.53%
Downside
33.54%
Upside
Check Amylyx Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
-1.5658
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.87
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
-156.8M
Revenue (TTM)
-665.0K
Profit Margin
0.00%
Return On Equity TTM
-56.53%
Track how Amylyx Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Amylyx Pharmaceuticals, Inc. in the last 5 years
Lowest (-21.78x)
June 30, 2023
Today (-0.87x)
November 14, 2025
Industry (-0.81x)
November 14, 2025
Highest (23.35x)
March 31, 2024
Today’s Price to Earnings Ratio: -0.87x
Compare market cap, revenue, PE, and other key metrics of Amylyx Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.4B | NA | -0.87 | 0.00% | |
| BUY | $59.8B | 235.01% | 1414.81 | 1.36% | |
| NA | $40.9B | NA | 712.21 | 1.38% | |
| BUY | $110.2B | 92.67% | 30.58 | 31.35% | |
| BUY | $71.6B | 22.7% | 16.34 | 32.13% |
The Amylyx Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Amylyx Pharmaceuticals, Inc. investment value today
Current value as on today
₹2,58,183
Returns
₹1,58,183
(+158.18%)
Returns from Amylyx Pharmaceuticals, Inc. Stock
₹1,52,988 (+152.99%)
Dollar Returns*
₹5,194 (+5.19%)
Based on 13 analysts
53.85%
Buy
46.15%
Hold
0.00%
Sell
Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Amylyx Pharmaceuticals, Inc.. Average target price of $20.33
Get share price movements and forecasts by analysts on Amylyx Pharmaceuticals, Inc..
What analysts predicted
37.53%UPSIDE
Target Price
$20.33
Current Price
$12.7
Analyzed by
13 Analysts
Target
$20.33
Amylyx Pharmaceuticals, Inc. target price $20.33, a slight upside of 37.53% compared to current price of $12.7. According to 13 analysts rating.
Search interest for Amylyx Pharmaceuticals, Inc. Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, AMLX stock has moved up by 47.7%
Best in 1 Year
![]()
In the last 1 year, AMLX has outperformed top 5 stocks with highest market-cap in its industry
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -41.44M → -34.38M (in $), with an average increase of 20.5% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 81.5% return, outperforming this stock by 146.0%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 416.0K → -665.0K (in $), with an average decrease of 259.9% per quarter
| Organisation | Amylyx Pharmaceuticals, Inc. |
| Headquarters | 43 Thorndike Street, Cambridge, MA, United States, 02141 |
| Industry | Services |
| CEO | Mr. Joshua B. Cohen |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. James M. Frates M.B.A. | Chief Financial Officer |
Ms. Gina M. Mazzariello J.D. | Chief Legal Officer & General Counsel |
Mr. Tom Holmes | Chief Technical Operations Officer |
Ms. Tammy Sarnelli | Global Head of Regulatory Affairs |
Dr. Machelle Manuel Ph.D. | VP & Head of Global Medical Affairs |
Mr. Joshua B. Cohen | Co-Founder, Co-CEO & Director |
Mr. Justin B. Klee | Co-Founder, Co-CEO & Director |
Ms. Lindsey Allen | Head of Investor Relations & Communications |
Ms. Linda A. Arsenault | Chief Human Resources Officer |
Dr. Jamie Timmons | Head of Global Medical Strategy & Communications |
Amylyx Pharmaceuticals, Inc. share price today is $12.7 as on at the close of the market. Amylyx Pharmaceuticals, Inc. share today touched a day high of $12.8 and a low of $12.15.
Amylyx Pharmaceuticals, Inc. share touched a 52 week high of $16.96 on and a 52 week low of $2.6 on . Amylyx Pharmaceuticals, Inc. stock price today i.e. is closed at $12.7,which is 25.12% down from its 52 week high and 388.46% up from its 52 week low.
Amylyx Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Amylyx Pharmaceuticals, Inc. (AMLX) shares with as little as ₹88.7 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.00 in Amylyx Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amylyx Pharmaceuticals, Inc. share’s latest price of $12.7 as on November 15, 2025 at 2:29 am IST, you will get 0.7874 shares of Amylyx Pharmaceuticals, Inc.. Learn more about
fractional shares .